(Q46378373)

21 December 2017

title

Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health center (English)

1 reference

21 December 2017

1 reference

1 reference

Laura Shane-McWhorter

series ordinal

1

1 reference

21 December 2017

Gary M Oderda

series ordinal

2

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

21 December 2017

published in

Pharmacotherapy

1 reference

21 December 2017

volume

25

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

96-109

1 reference

21 December 2017

Barriers to providing diabetes care in community health centers

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Quality of diabetes care in community health centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Dietary composition, body weight, and NIDDM. Comparison of high-fiber, high-carbohydrate, and modified-fat diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Economic costs of diabetes in the US in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

A diabetes report card for the United States: quality of care in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Medical care for patients with diabetes. Epidemiologic aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Pharmacist involvement in Healthy People 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

The Asheville Project: short-term outcomes of a community pharmacy diabetes care program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Management of patients with type 2 diabetes by pharmacists in primary care clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Effect of a pharmacist-managed diabetes care program in a free medical clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

The new credential: advanced diabetes management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Potential short-term economic benefits of improved glycemic control: a managed care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Effect of improved glycemic control on health care costs and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Improving aspirin prophylaxis in a primary care diabetic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.25.1.96.55623

10.1592/PHCO.25.1.96.55623

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017